Press
New statistical approach to COVID-19 clinical trials aims to accelerate drug approval process and attract more funding
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
May 18, 2020
